This page has moved to here!
Hematologic Malignancy Cancer Clinical Trials
The University of Vermont Cancer Center has many trials specifically focused on hematologic malignancy cancer research.
COG AAML08B1 - Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)
|Purpose: This research study is looking at blood samples from newborns with Down syndrome.|
|ClinicalTrials.gov Identifier: NCT00959283|
|Primary/Site/Co Investigator: Alan C. Homans, MD|
|Contact: Alan Homans (802) 847-2850|
|Institution Number: M11-185|
|Protocol Research Type: Cooperative Group|
Last modified December 02 2016 09:38 AM